Results from PIONEER: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis (ISM)

Authors :: Maurer, M.
Elberink, H. O.
Gotlib, J.
Sabato, V.
Hartmann, K.
Broesby-Olsen, S.
Castells, M.
Deininger, M. W.
Heaney, M. L.
George, T. I.
Siebenhaar, F.
Radia, D.
Triggiani, M.
van Daele, P.
Deangelo, D. J.
Schmidt-Kittler, O.
Lin, H. -M.
Morrison, A.
Mar, B.
Akin, C.
Source :: Maurer, M, Elberink, H O, Gotlib, J, Sabato, V, Hartmann, K, Broesby-Olsen, S, Castells, M, Deininger, M W, Heaney, M L, George, T I, Siebenhaar, F, Radia, D, Triggiani, M, van Daele, P, Deangelo, D J, Schmidt-Kittler, O, Lin, H-M, Morrison, A, Mar, B & Akin, C 2020, ' Results from PIONEER: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis (ISM) ', Oncology Research and Treatment, vol. 43, no. Suppl. 4, 384, pp. 77 . < https://doi.org/10.1159/000510995 >
Publication Year :: 2020

Language :: English
Database :: OpenAIRE
Journal :: Maurer, M, Elberink, H O, Gotlib, J, Sabato, V, Hartmann, K, Broesby-Olsen, S, Castells, M, Deininger, M W, Heaney, M L, George, T I, Siebenhaar, F, Radia, D, Triggiani, M, van Daele, P, Deangelo, D J, Schmidt-Kittler, O, Lin, H-M, Morrison, A, Mar, B & Akin, C 2020, ' Results from PIONEER: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis (ISM) ', Oncology Research and Treatment, vol. 43, no. Suppl. 4, 384, pp. 77 . < https://doi.org/10.1159/000510995 >
Accession number :: edsair.od......3062..b5e8e55a7cafacd6fadbeed0a103d6d7

Tools